| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/02/2001 | WO2000055191A3 Recombinant haemophilus influenzae adhesin proteins |
| 08/02/2001 | WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011093 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 08/02/2001 | US20010011092 High affinity ligands for nociceptin receptor ORL-1 |
| 08/02/2001 | US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | DE10004157A1 New pyridyl- or pyrimidinyl-substituted bicyclic pyrrole derivatives, are cyclokine release inhibitors useful for treating immune system-related disorders, e.g. cancer, multiple sclerosis or arthritis |
| 08/02/2001 | CA2398642A1 Mucin synthesis inhibitors |
| 08/02/2001 | CA2398615A1 Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments |
| 08/02/2001 | CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398466A1 Ultra high affinity neutralizing antibodies |
| 08/02/2001 | CA2397758A1 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate |
| 08/02/2001 | CA2396640A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | CA2297706A1 Anticonvulsive and antiallergic/anti-asthmatic pyrazolo-(3,4-d)pyrimidines having affinity for the adenosine receptor, and process for their preparation |
| 08/01/2001 | EP1120417A2 Xanthine derivatives for the treatment of cerebrovascular disorders |
| 08/01/2001 | EP1120409A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 08/01/2001 | EP1119573A2 Bipyridine manganese complexes |
| 08/01/2001 | EP1119555A1 Biphenylene lactams as prostaglandin receptor ligands |
| 08/01/2001 | EP1119552A1 Ureidopiperidine derivatives as selective human nk 3? receptor antagonists |
| 08/01/2001 | EP1119551A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 08/01/2001 | EP1119544A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators |
| 08/01/2001 | EP1119542A1 Prostaglandin receptor ligands |
| 08/01/2001 | EP1119375A1 Methods and adjuvants for stimulating mucosal immunity |
| 08/01/2001 | EP1119372A1 Composition and method for treating allergic diseases |
| 08/01/2001 | EP1119357A1 C3a receptor ligands |
| 08/01/2001 | EP1119355A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | EP1119334A1 Two chamber cartridge for atomizers |
| 08/01/2001 | EP1119253A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 08/01/2001 | EP0862567B1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 08/01/2001 | EP0737074B1 Botulinum toxins for treating hyperhydrosis |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306512A Heterocyclic inhibitors of P38 |
| 08/01/2001 | CN1306433A Use of chemically-stabilized chlorite solution for inhibiting antigen-specific immune response |
| 08/01/2001 | CN1306429A Use of glucocorticosteriod for mfg. medicament for treating mild/early forms of COPD (chronic obstructive pulmonary disease) |
| 08/01/2001 | CN1306428A Inhibitors of transcription factor NF-KB |
| 08/01/2001 | CN1306420A Methods for treating capules and dry powdered pharmaceutical formulations |
| 08/01/2001 | CN1305989A Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
| 08/01/2001 | CN1305836A Medicine for treating epistaxis |
| 08/01/2001 | CN1305819A Application method of anastaltic Chinese medicine |
| 08/01/2001 | CN1305818A Fujiu syrup for preventing and treating cough and asthma |
| 08/01/2001 | CN1069098C Novel imidazole derivative and process for producing same |
| 08/01/2001 | CN1069053C Oral medicine for curing phelgm-heat cough |
| 07/31/2001 | US6268533 Reacting 4-benzyloxy-3-formamidostyrene oxide with an optically pure 4-methoxy-.alpha.-methyl-n-(phenylmethyl)benzeneethanamine followed by reduction to produce formoterol |
| 07/31/2001 | US6268393 Calanolides and analogues thereof |
| 07/31/2001 | US6268382 Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients |
| 07/31/2001 | US6268379 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 07/31/2001 | US6268344 Associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and other transplantations, severe burns, pregnancy, major surgery, severe trauma, or ards. |
| 07/31/2001 | US6268338 Cyclohexapeptidyl amine compounds |
| 07/31/2001 | US6268337 Methods for treating vascular disorders using activated protein C |
| 07/31/2001 | US6268177 An isolated polynucleotide; therapy and treatment of streptococcal infections, pneumonia, meningitis, sinusitis, conjunctivitis; screening for antibiotics |
| 07/31/2001 | US6268172 A polynucleotide encoding a polypeptide for histidine kinase; screening and development of antibiotics for streptococcal diseases; otitis media, conjunctivitis, pneumonia, bacteremia pleural empyema, menegitis, sinusitis |
| 07/31/2001 | CA2118119C Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 07/31/2001 | CA2041240C Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds |
| 07/26/2001 | WO2001053353A2 Recombinant antibodies to human interkleukin-1 beta |
| 07/26/2001 | WO2001053295A1 Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin |
| 07/26/2001 | WO2001053291A1 Benzimidazole derivatives |
| 07/26/2001 | WO2001053279A1 Urea compounds as inhibitors for vla-4 |
| 07/26/2001 | WO2001053272A1 Human chymase inhibitors |
| 07/26/2001 | WO2001053266A1 Therapeutic morpholino-substituted compounds |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053261A1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 07/26/2001 | WO2001053256A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 07/26/2001 | WO2001052845A1 Gyrase inhibitors and uses thereof |
| 07/26/2001 | WO2001052815A1 Multi-step drug dosage forms |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2001014886A3 Inhibitors of binding between proteins and macromolecular ligands |
| 07/26/2001 | WO2001013891A3 Modulation of release from dry powder formulations |
| 07/26/2001 | WO2000071741A9 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | US20010009917 Reducing associated adverse effects; 5-lipoxygenase inhibitor, useful in treatment of conditions related to elevated leukotriene levels |
| 07/26/2001 | US20010009915 Nitrogen oxide yielding and thromboxane A2 (TXA2) and serotonin (5HT2) receptor antagonist; treatment of atherothrombotic cardiovascular disorders |
| 07/26/2001 | DE10002509A1 New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders |
| 07/26/2001 | CA2398061A1 Substituted glutarimides and their use as inhibitors of il-12 production |
| 07/26/2001 | CA2397686A1 Gyrase inhibitors and uses thereof |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397531A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2396908A1 Benzimidazole derivative |
| 07/26/2001 | CA2396212A1 Recombinant antibodies to human interleukin-1 beta |
| 07/26/2001 | CA2395974A1 Multi-step drug dosage forms |
| 07/26/2001 | CA2365118A1 Inhibitor against human chymase activity |
| 07/25/2001 | EP1118680A1 Method for the diagnosis of polymorphisms in the human PDH E1alpha gene |
| 07/25/2001 | EP1118678A1 Method for diagnosing polymorphisms in the human PDH E1 beta gene |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118615A1 Novel salts of pyridopyrazine compound and crystals thereof |
| 07/25/2001 | EP1118610A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/25/2001 | EP1118327A1 Preventive and/or therapeutic agents for sinusitis-------------- |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117776A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 07/25/2001 | EP1117658A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 07/25/2001 | EP1117657A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 07/25/2001 | EP1117653A1 Chemical compounds |
| 07/25/2001 | EP1117651A1 New bis-benzimidazoles |
| 07/25/2001 | EP1117644A1 Benzamide derivatives as thrombin inhibitors |
| 07/25/2001 | EP1117643A1 New crystal modification iii of torasemide |
| 07/25/2001 | EP1117640A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 07/25/2001 | EP1117628A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |